Grant of Stock Options pursuant to Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022

29th July, 2026 BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex, Mumbai- 400 001 Bandra (East), Mumbai – 400 051 BSE scrip code: 543635 NSE symbol: PPLPHARMA Sub: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) Grant of stock options pursuant to Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022 (‘Plan 2022’) Dear Sir / Madam, Pursuant to Regulation 30 read with Schedule III to the SEBI Listing Regulations, we wish to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held on Wednesday, 29th July, 2026 approved grant of upto 56,36,436 stock options under the Plan 2022. The disclosure as required under Regulation 30 of SEBI Listing Regulations is enclosed herewith as Annexure-1. You are requested to take the above information on your record. Thank you. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Encl: As above Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T: +91 22 3802 3000 / 4000; Email: shareholders.ppl@piramal.com piramalpharma.com Annexure I Sr. No. Particulars Details 1. Brief details of options 56,36,436 Options under Piramal Pharma Limited granted – Employee Stock Option and Incentive Plan 2022 2. Whether the scheme is in Yes terms of SEBI (SBEB) Regulations, 2021 (if applicable) 3. Total number of shares 56,36,436 equity shares covered by these options 4. Pricing formula Options have been granted at an exercise price of Rs.10/- per option 5. Options vested All location except US • 1/3rd would vest on 29 July 2027 and be exercisable till 28 July 2032 • 1/3rd would vest on 29 July 2028 and be exercisable till 28 July 2033 • 1/3rd would vest on 29 July 2029 and be exercisable till 28 July 2034 • 2/3rd would vest on 29 July 2027 and be exercisable till 28 July 2032 • 1/3rd would vest on 29 July 2028 and be exercisable till 28 July 2033 • 70% would vest on 29 July 2027 and be exercisable till 28 July 2032 • 30% would vest on 29 July 2028 and be exercisable till 28 July 2033 • 1/3rd would vest on 29 July 2027 and be exercisable till 15 March 2028 • 1/3rd would vest on 29 July 2028 and be exercisable till 15 March 2029 • 1/3rd would vest on 29 July 2029 and be exercisable till 15 March 2030 Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T: +91 22 3802 3000 / 4000; Email: shareholders.ppl@piramal.com piramalpharma.com 6. Time within which option Options can be exercised within 5 years may be exercised commencing from the date of vesting of each tranche. For US, Vested Options shall be Exercised within the period mentioned in the schedule above under US Options vested. Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T: +91 22 3802 3000 / 4000; Email: shareholders.ppl@piramal.com piramalpharma.com